Testis cancer--progress in risk assessment for occult retroperitoneal lymph node metastases

Editorial

S P Lerner. J Urol. 1996 Feb.

. 1996 Feb;155(2):593-4.

doi: 10.1016/s0022-5347(01)66460-7.

No abstract available

Comment on

Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors.
Albers P, Ulbright TM, Albers J, Miller GA, Orazi A, Crabtree WN, Baniel J, Reister T, Sidner RA, Foster RS, Donohue JP. Albers P, et al. J Urol. 1996 Feb;155(2):579-86. J Urol. 1996. PMID: 8558664
The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
Saxman SB, Nichols CR, Foster RS, Messemer JE, Donohue JP, Einhorn LH. Saxman SB, et al. J Urol. 1996 Feb;155(2):587-9. J Urol. 1996. PMID: 8558665
Incidence and management of testicular carcinoma metastatic to the neck.
See WA, Laurenzo JF, Dreicer R, Hoffman HT. See WA, et al. J Urol. 1996 Feb;155(2):590-2. J Urol. 1996. PMID: 8558666